
Stanford Vascular
@StanfordVasc
Followers
1K
Following
37
Media
152
Statuses
431
Division of Vascular Surgery at Stanford
Stanford, CA
Joined October 2021
FDA has cleared Bunkerhill AAQ, the first AI algorithm to automatically measure abdominal aortic diameter on CT scans with or without contrast. Developed at Stanford by Dr. @DrAalami and Adrit Rao. 🔗 Read the story:
1
0
4
RT @StanfordSurgery: 🚨 New Episode Alert 🚨 We’re joined by Stanford’s Chief of Vascular Medicine, @NickLeeper78! . 🔗 Tune in here: https://….
0
2
0
New from Dr. Arash Fereydooni in @JACCJournals: 🩸 A rare case of metastatic popliteal angiosarcoma in a patient with Loeys-Dietz syndrome led to fatal hemorrhage—highlighting the need to consider malignancy in atypical vascular bleeding. 🔗:
0
3
5
🏆 Awards & Recognitions:.- Dr. @ChandraVenita completed her tenure as Residency Program Director and received this year’s Teaching Award.- Dr. Michael David Sgroi steps into the role as our new Residency Program Director.- Dr. @atfisherMD was honored with the Top VSITE Award
1
0
3
@MayoClinic 💬 Parting advice: “Dare to pursue anything you desire—the possibilities are endless at Stanford, and there is an incredible team of people who want to help make your dreams a reality.” ✨..Wishing you all the best, Dr. Iceton. 💫.
1
1
2
@MayoClinic 🗣️ What he says he’ll miss most about Stanford: “The daily interactions with the amazing team members.” 🤝.
1
1
2
@MayoClinic 💡 His clinical interests center on the care of venous hypertension and chronic wounds, where he’s dedicated to improving outcomes for patients with complex vascular conditions.
1
0
2
🎓 Graduating Vascular Medicine Fellow Feature: Blake Iceton, MD 🎓..🌟 Post-graduation, Dr. Iceton will be taking a well-deserved 3-month travel break before beginning his new role as a Vascular Medicine Consultant at the @mayoclinic! 🌍✈️
1
1
8
🧪🧠 New in @sciencemagazine from @NickLeeper78: The antipsychotic thiothixene boosts macrophage clearance of dying cells—efferocytosis—by blocking dopamine signaling. Could open doors for treating atherosclerosis, cancer, and chronic inflammation. 🔗:
0
1
4
📊 New in @avsgjournal from Drs. @ChandraVenita & Arash Fereydooni: 2024 vascular surgery applicants preferred virtual interviews (57%)—but 66% moved programs up after second-look visits. 🔗:
0
1
2
🧬 Genome-wide study from Dr. Shaunak Adkar in @Circ_Gen identifies 5 novel loci linked to intracranial aneurysm and implicates pericytes & smooth muscle cells—pointing to matrix deficits as a potential driver, independent of smoking or hypertension. 🔗:
1
2
9
🧬 New from @Nazish_Sayed in @CircAHA: Using in silico screening and patient-derived stem cell models, researchers identify olmesartan as a promising therapy for LMNA-related cardiomyopathy—a novel approach to treating genetic heart failure. 🔗:
0
2
0
@VascularSVS Highlights:.🔹 Dr. Jason Lee led as Program Chair.🔹 @ChandraVenita advised applicants.🔹 Dr. Goldstone asked, “Who put the Vascular in Vascular Surgery?”.🔹 Talks by @CabotMD, @atfisherMD, & @KeyureeS.🔹 Student/RN standouts: Emily Eshraghian, Ethan Farah & Alexandra Haro #VAM25
1
1
9
@VascularSVS From cutting-edge genomics and AI-driven risk prediction to new approaches in trauma, dialysis access, complex aortic repair and limb salvage—our team is pushing the field forward. 💪🩺🧠 #VAM25
1
1
5
We had a strong showing at this year’s Vascular Annual Meeting, with our faculty and trainees delivering an impressive range of podium talks, panel discussions, and posters. @VascularSVS #VAM25
1
1
20